SCHEMBL17494147

SCHEMBL17494147

CC(C)CCc1nc2cc(Br)ccc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 4/20 0.52
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
LMNA P02545 2/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 2/20 0.40
RAB9A P51151 2/20 0.39
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17493843 0.88 AAK1 (0.63) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL12350646 0.79 DDAH1 (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL31144682 0.79 SLC6A4 (0.43) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4117396 0.78 POLB (0.66) AAK1POLBRAB9ANPC1
SCHEMBL17653083 0.77 AAK1 (0.45) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL17653191 0.77 TUBB4A (0.46) AAK1ALDH1A1MAPK1RAB9AMAPT
SCHEMBL28381626 0.77 HDAC3 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1976712 0.76 TDP1 (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL13628993 0.76 RAB9A (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL31570020 0.76 TDP1 (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177604-A1 HETEROCYCLIC KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2017-06-14 EP disclosed
WO-2016022312-A1 HETEROCYCLIC KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-02-11 WO disclosed